Article Type
Changed
Thu, 07/19/2018 - 09:32
Display Headline
Point and Counterpoint: Is medical therapy as good as PCI in stable angina? Two views
Interpreting the COURAGE trial
Article PDF
Author and Disclosure Information

Deepak L. Bhatt, MD
Associate Director, Cardiovascular Coordinating Center, and Staff, Cardiac, Peripheral, and Carotid Intervention, Department of Cardiovascular Medicine, Cleveland Clinic; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Address: Deepak L. Bhatt, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: bhattd@ccf.org

Dr. Bhatt has disclosed that he has received grants, research support, or honoraria from Astra Zeneca, Bristol Myers Squibb, Cardax, Centocor, Cogentus, Daiichi-Sankyo, Eisai, Eli Lilly, Ethicon, Glaxo Smith Kline, Johnson and Johnson, McNeill, Medtronic, Millennium, Otsuka, Paringenix, PDL, Sanofi Aventis, Schering Plough, The Medicines Company, tns Healthcare, and Vertex; he currently donates all honoraria to nonprofit organizations.

Issue
Cleveland Clinic Journal of Medicine - 74(9)
Publications
Topics
Page Number
618, 620
Sections
Author and Disclosure Information

Deepak L. Bhatt, MD
Associate Director, Cardiovascular Coordinating Center, and Staff, Cardiac, Peripheral, and Carotid Intervention, Department of Cardiovascular Medicine, Cleveland Clinic; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Address: Deepak L. Bhatt, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: bhattd@ccf.org

Dr. Bhatt has disclosed that he has received grants, research support, or honoraria from Astra Zeneca, Bristol Myers Squibb, Cardax, Centocor, Cogentus, Daiichi-Sankyo, Eisai, Eli Lilly, Ethicon, Glaxo Smith Kline, Johnson and Johnson, McNeill, Medtronic, Millennium, Otsuka, Paringenix, PDL, Sanofi Aventis, Schering Plough, The Medicines Company, tns Healthcare, and Vertex; he currently donates all honoraria to nonprofit organizations.

Author and Disclosure Information

Deepak L. Bhatt, MD
Associate Director, Cardiovascular Coordinating Center, and Staff, Cardiac, Peripheral, and Carotid Intervention, Department of Cardiovascular Medicine, Cleveland Clinic; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Address: Deepak L. Bhatt, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: bhattd@ccf.org

Dr. Bhatt has disclosed that he has received grants, research support, or honoraria from Astra Zeneca, Bristol Myers Squibb, Cardax, Centocor, Cogentus, Daiichi-Sankyo, Eisai, Eli Lilly, Ethicon, Glaxo Smith Kline, Johnson and Johnson, McNeill, Medtronic, Millennium, Otsuka, Paringenix, PDL, Sanofi Aventis, Schering Plough, The Medicines Company, tns Healthcare, and Vertex; he currently donates all honoraria to nonprofit organizations.

Article PDF
Article PDF
Related Articles
Interpreting the COURAGE trial
Interpreting the COURAGE trial
Issue
Cleveland Clinic Journal of Medicine - 74(9)
Issue
Cleveland Clinic Journal of Medicine - 74(9)
Page Number
618, 620
Page Number
618, 620
Publications
Publications
Topics
Article Type
Display Headline
Point and Counterpoint: Is medical therapy as good as PCI in stable angina? Two views
Display Headline
Point and Counterpoint: Is medical therapy as good as PCI in stable angina? Two views
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media